News Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Continue Reading Previous New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral ClearanceNext Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Related Stories News Syncron Expands Integration Capabilities to Connect Aftermarket Intelligence with Enterprise Data Platforms News Solulu Tech Expands Stablecoin Infrastructure to Support Cross-Border Payments and Multi-Currency Settlement News Beach Day API Launches Real-Time Beach and Ocean Data API for Developers News Mission Control AI Introduces Bob, a Wearable That Captures Expert Knowledge Where the Work Happens News SVT Robotics Surpasses Four Billion Transactions on its SOFTBOT Platform News Lung Fung (2290) Achieves Record-High Annual Revenue and Net Profit
